Mianserin treatment of patients with
psychosis induced by antiparkinsonian drugs
by
Ikeguchi K, Kuroda A
Department of Neurology,
Jichi Medical School, Tochigiken, Japan. .
Eur Arch Psychiatry Clin Neurosci 1995; 244(6):320-4

ABSTRACT

We evaluated the effects of mianserin, a relatively selective 5-HT2 receptor antagonist, on symptoms related to drug-induced psychosis in patients with Parkinson's disease (PD). A total of 12 patients with PD who had developed drug-induced psychosis showed delirium (DSM-III-R criteria; n = 10) and pure visual hallucinations (n = 2). The antiparkinsonian drugs involved in the drug-induced psychosis were L-DOPA/carbidopa, bromocriptine, trihexyphenidyl, and amantadine. They received mianserin (mean 36.7 mg, range 20-60 mg) given orally for 8 weeks. Complete relief or marked improvement in psychotic symptoms was noted in 8 patients, moderate improvement in 2 patients, and no effect in 2 patients. The parkinsonian disability also decreased slightly in 8 patients. These results suggest that serotonin antagonism at 5-HT2 receptors may not only play an important role in the treatment of drug-induced psychosis in PD, but may also ameliorate the symptoms of parkinsonism.

5-HT2
Isatin
L-Dopa
Mianserin
Cabergoline
Amantadine
Bromocriptine
Antipsychotics
Parkinson's disease
Pramipexole : review
Advanced Parkinson's disease
Parkinson's disease: resources
Dopamine, gambling and sex manias
Hedonistic homeostatic dysregulation

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family